A Tale of Two Lung Diseases 
Caring for At-risk Patients and Recognizing Differences in Pulmonary Fibrosis During the Pandemic
Let’s Begin
Overview
“It was the best of times, it was the worst of times, it was the age of wisdom” – Charles Dickens, A Tale of Two Cities
2020 will be one for the books. COVID-19 continues to burden US healthcare systems amidst the ongoing pandemic. Patients with progressive chronic fibrosing interstitial lung diseases (CF-ILDs) are among the patients at higher risk for severe illness and complications secondary to COVID-19. And, there is the potential for development of progressive pulmonary fibrosis in patients recovering from COVID-19-induced acute lung injury and acute respiratory distress syndrome (ARDS). This educational series will explore the presentation, impact, management, and follow-up of patients who present with either of these two conditions. This educational series is approved for AMA PRA Category 1 CreditTM.
move the white bar to see the difference
Education
Immerse yourself in a series of pulmonology and radiology expert-led educational activities that range from a virtual panel to several vlogs and an e-Newsletter. Activities will be added as they become available.
Faculty
Melany Atkins, MD
Jonathan Chung, MD
Christopher King, MD, FACP, FCCP
Paul Noble, MD
Imre Noth, MD
Glenn Wortmann, MD, FIDSA, FACP
Tanzira Zaman, MD
Melany Atkins, MD
Medical Director, Advanced Cardiovascular Imaging
Inova Fairfax Hospital
Director of Cardiac Imaging
Fairfax Radiological Consultants
Fairfax, VA
Jonathan Chung, MD
Vice Chair of Quality, Department of Radiology
Section Chief, Thoracic Radiology
Professor of Radiology
The University of Chicago Medicine
Chicago, IL
Christopher King, MD, FACP, FCCP
Director, Transplant and Advanced Lung Disease Critical Care Program
Inova Fairfax Hospital
Assistant Clinical Professor
Virginia Commonwealth University
Falls Church, VA
Paul Noble, MD
Professor and Chair, Department of Medicine
Director, Women’s Guild Lung Institute
Vera and Paul Guerin Family Distinguished Chair in Pulmonary Medicine
Physician-in-Chief
Cedars-Sinai Medical Center
Los Angeles, CA
Imre Noth, MD
Chief of Pulmonary & Critical Care Medicine
Professor of Medicine
University of Virginia School of Medicine
Charlottesville, VA
Glenn Wortmann, MD, FIDSA, FACP
Section Director, Infectious Diseases
MedStar Washington Hospital Center
Medical Director, Infection Prevention
MedStar Quality and Safety
Professor of Medicine
Uniformed Services University of the Health Sciences
Washington, DC
Tanzira Zaman, MD
Medical Director, Interstitial Lung Disease Program
Division of Pulmonary & Critical Care Medicine
Cedars-Sinai Medical Center
Los Angeles, CA
